hydralazine has been researched along with Carcinoma, Bronchial in 2 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hydralazine has been shown to reduce tumour blood flow and to potentiate the cytotoxicity of melphalan and bioreductive agents in mice." | 1.28 | The effects of single dose oral hydralazine on blood flow through human lung tumours. ( Cronin, B; Flower, MA; Horwich, A; McCready, VR; Rowell, NP, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rowell, NP | 2 |
| Flower, MA | 1 |
| McCready, VR | 1 |
| Cronin, B | 1 |
| Horwich, A | 1 |
| Clark, K | 1 |
2 other studies available for hydralazine and Carcinoma, Bronchial
| Article | Year |
|---|---|
The effects of single dose oral hydralazine on blood flow through human lung tumours.
Topics: Administration, Oral; Aged; Carcinoma, Bronchogenic; Dose-Response Relationship, Drug; Female; Human | 1990 |
The effects of oral hydralazine on blood pressure, cardiac output and peripheral resistance with respect to dose, age and acetylator status.
Topics: Acetylation; Administration, Oral; Age Factors; Aged; Blood Pressure; Carcinoma, Bronchogenic; Cardi | 1990 |